BASF AG’s time and extent application does not support adding octyl triazone to the OTC sunscreen monograph, FDA says in its third finding this year that a TEA for sunscreen ingredients is inadequate.
FDA’s decisions on the three TEAs could concern advocates on Capitol Hill and in the industry who want to use the TEA process to expand the OTC sunscreen monograph. However,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?